ROYCE & ASSOCIATES LP - ANACOR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$6,609,000
-53.0%
58,500
-51.0%
0.04%
-48.0%
Q3 2015$14,066,000
+13.9%
119,500
-25.1%
0.08%
+44.2%
Q2 2015$12,350,000
-25.0%
159,500
-43.9%
0.05%
-16.1%
Q1 2015$16,458,000
+49.9%
284,500
-16.4%
0.06%
+63.2%
Q4 2014$10,981,000
+31.8%
340,5000.0%0.04%
+35.7%
Q3 2014$8,332,000340,5000.03%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$61,778,00025.76%
VHCP Management, LLC 1,178,474$68,175,00015.70%
Palo Alto Investors LP 3,259,045$188,536,0009.32%
HWG Holdings LP 69,898$4,044,0006.53%
Consonance Capital Management LP 830,151$48,024,0004.37%
EMORY UNIVERSITY 23,325$1,349,0002.55%
Baker Brothers Advisors 4,204,702$243,242,0002.02%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 117,875$6,819,0001.55%
KINGDON CAPITAL MANAGEMENT, L.L.C. 595,300$34,438,0001.46%
Century Capital Management, LLC 1,030,483$45,609,0001.31%
View complete list of ANACOR PHARMACEUTICALS INC shareholders